XLONKAY
Market cap131mUSD
Dec 06, Last price
19.00GBP
Name
Kings Arms Yard VCT PLC
Chart & Performance
P/E
4,956.90
P/S
2,203.98
EPS
0.00
Div Yield, %
0.04%
Shrs. gr., 5y
11.30%
Rev. gr., 5y
-8.50%
Revenues
5m
+307.46%
Net income
2m
+194.21%
CFO
-1m
L
Dividend
Oct 03, 20240.1 GBP/sh
Earnings
Apr 17, 2025
Profile
Kings Arms Yard VCT PLC operates as a venture capital trust. It does not invest in companies that deal in property or shares and securities, insurance, banking, agriculture. The fund invests primarily in securities of unquoted companies and in companies whose shares are traded on Alternative Investment Market operating in the areas of information and communication technologies, and healthcare. It invests in United Kingdom and invests in shares or securities including loans with a five year or greater maturity period. It also invests in a portfolio of listed equities and fixed interest securities. The gross assets of a portfolio company must not exceed £15 million ($17.39 million) immediately prior to the investment and £16 million ($18.55 million) immediately thereafter. The maximum each portfolio company can receive from State Aided risk capital schemes is £5 million ($5.80 million) in any twelve month period. Portfolio companies may have up to 250 employees.
IPO date
Feb 26, 1996
Employees
0
Domiciled in
GB
Incorporated in
GB
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | |||||||||
Revenues | 4,804 307.46% | 1,179 -92.84% | |||||||
Cost of revenue | 7,076 | 2,590 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | (2,272) | (1,411) | |||||||
NOPBT Margin | |||||||||
Operating Taxes | 726 | ||||||||
Tax Rate | |||||||||
NOPAT | (2,272) | (2,137) | |||||||
Net income | 2,136 194.21% | 726 -95.47% | |||||||
Dividends | (4,644) | (9,218) | |||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | 4,073 | 10,672 | |||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | 19 | ||||||||
Net debt | (104,301) | (102,885) | |||||||
| Cash flow | |||||||||
Cash from operating activities | (1,092) | 726 | |||||||
CAPEX | |||||||||
Cash from investing activities | (4,280) | (6,431) | |||||||
Cash from financing activities | (611) | 1,402 | |||||||
FCF | (4,114) | (1,141) | |||||||
| Balance | |||||||||
Cash | 20,196 | 26,179 | |||||||
Long term investments | 84,105 | 76,706 | |||||||
Excess cash | 104,061 | 102,826 | |||||||
Stockholders' equity | 84,102 | 90,111 | |||||||
Invested Capital | 22,083 | 14,547 | |||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | 516,008 | 471,274 | |||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | (2,272) | (1,411) | |||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||